Shilpa Medicare ties up with Cadila Healthcare

24 Sep 2021 Evaluate

Shilpa Medicare, via its wholly owned subsidiary, Shilpa Biologicals (SBPL), has entered into a definitive agreement with Cadila Healthcare (CHL) for production-supply of the ZyCov-D vaccine drug substance from its integrated Biologics R&D cum Manufacturing center at Dharwad, Karnataka.

The targeted production of the ZyCoV-D vaccine from this facility will be mutually agreed upon by both parties.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

530.70 -4.45 (-0.83%)
24-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.35
Dr. Reddys Lab 5962.50
Cipla 1400.00
Zydus Lifesciences 933.40
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.